Shattuck Labs (STTK) Research & Development (2019 - 2026)
Shattuck Labs' (STTK) quarterly Research & Development came in at $10.9 million in Q1 2026, up 10.35% year-on-year from $9.9 million in Q1 2025, and up 20.88% on a QoQ basis from $9.1 million in Q4 2025.
Shattuck Labs (STTK) Research & Development (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Research & Development data on file, last reported at $10.9 million in Q1 2026.
- On a quarterly basis, Research & Development rose 10.35% year-over-year to $10.9 million in Q1 2026; TTM through Mar 2026 was $36.3 million, a 40.36% decrease from a year earlier, with the FY2025 full-year figure at $35.3 million, down 47.52% from the prior year.
- Research & Development for Q1 2026 stood at $10.9 million, up from $9.1 million in the prior quarter.
- Over the last five years, Research & Development for STTK reached as high as $24.2 million in Q3 2023 and fell as low as $7.6 million in Q3 2025.
- Historically, Research & Development has averaged $15.9 million across 5 years, with a median of $16.3 million in 2024.
- Across the five-year window, Research & Development surged 85.61% in 2022 and plunged 54.88% in 2025, its largest moves.
- Year by year, Research & Development stood at $21.9 million in 2022, then sank by 30.43% to $15.2 million in 2023, then advanced by 1.1% to $15.4 million in 2024, then sank by 41.18% to $9.1 million in 2025, then advanced by 20.88% to $10.9 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $10.9 million in Q1 2026, $9.1 million in Q4 2025, and $7.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Shattuck Labs | 831.66 Mn | 831.66 Mn | - | 10.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.95 Mn |
| Dec 31, 2025 | 9.06 Mn |
| Sep 30, 2025 | 7.62 Mn |
| Jun 30, 2025 | 8.68 Mn |
| Mar 31, 2025 | 9.92 Mn |
| Dec 31, 2024 | 15.40 Mn |
| Sep 30, 2024 | 16.31 Mn |
| Jun 30, 2024 | 19.24 Mn |
| Mar 31, 2024 | 16.26 Mn |
| Dec 31, 2023 | 15.23 Mn |
| Sep 30, 2023 | 24.21 Mn |
| Jun 30, 2023 | 18.21 Mn |
| Mar 31, 2023 | 16.67 Mn |
| Dec 31, 2022 | 21.89 Mn |
| Sep 30, 2022 | 18.86 Mn |
| Jun 30, 2022 | 22.96 Mn |
| Mar 31, 2022 | 19.19 Mn |
| Dec 31, 2021 | 16.21 Mn |
| Sep 30, 2021 | 15.14 Mn |
| Jun 30, 2021 | 14.88 Mn |